Sydney - Thursday - August 28: (RWE Australian Business News) - Sigma Pharmaceuticals (ASX:SIP) says, in reply to an ASX query over a rise form $1.185 to $1.375, that it is not aware of any information that could explain the rise. It says the press has referred to speculation that hedge funds "were positioning for a break-up of the drug maker and wholesaler". However, Sigma is not aware of the source of this speculation and confirms that it is not currently considering a break-up of the company.
SIP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held